UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+3.8%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.77B
AUM Growth
-$242M
(-6%)
Cap. Flow
-$294M
Cap. Flow
% of AUM
-7.81%
Top 10 Holdings %
Top 10 Hldgs %
58.56%
Holding
566
New
99
Increased
122
Reduced
58
Closed
164
Top Buys
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$234M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$222M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$172M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$150M |
| 5 |
PRFT
Perficient Inc
PRFT
|
$79.6M |
Sector Composition
| 1 | Technology | 30.66% |
| 2 | Energy | 16.79% |
| 3 | Financials | 8.26% |
| 4 | Consumer Staples | 8.25% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
ProQR Therapeutics
PRQR
$258M
| $602K | 0.02% |
+227,020
| New | +$602K |
|
252
Mersana Therapeutics
MRSN
$34M
| $586K | 0.02% |
16,401
-6,400
| -28% | -$229K |
|
253
Autodesk
ADSK
$69.5B
| $586K | 0.02% |
1,983
-3,017
| -60% | -$892K |
|
254
Erasca
ERAS
$457M
| $576K | 0.02% |
229,600
+159,600
| +228% | +$401K |
|
|
NARI
255
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $567K | 0.02% |
11,102
-3,998
| -26% | -$204K |
|
|
INZY
256
DELISTED
Inozyme Pharma
INZY
| $557K | 0.01% |
201,232
-25,000
| -11% | -$69.3K |
|
257
Sutro Biopharma
STRO
$89.9M
| $553K | 0.01% |
300,621
-37,601
| -11% | -$69.2K |
|
|
THRD
258
DELISTED
Third Harmonic Bio
THRD
| $553K | 0.01% |
53,740
+1,446
| +3% | +$14.9K |
|
259
Marvell Technology
MRVL
$54.6B
| $552K | 0.01% |
5,000
-5,000
| -50% | -$552K |
|
260
Ventyx Biosciences
VTYX
$180M
| $534K | 0.01% |
244,000
+44,000
| +22% | +$96.4K |
|
261
Structure Therapeutics
GPCR
$1.27B
| $529K | 0.01% |
19,520
+1,520
| +8% | +$41.2K |
|
262
Toyota
TM
$260B
| $525K | 0.01% |
+2,700
| New | +$525K |
|
263
Asana
ASAN
$3.18B
| $507K | 0.01% |
25,000
| – | – |
|
264
Elastic
ESTC
$9.21B
| $495K | 0.01% |
+5,000
| New | +$495K |
|
265
C4 Therapeutics
CCCC
$194M
| $494K | 0.01% |
137,360
+114,360
| +497% | +$412K |
|
266
Wave Life Sciences
WVE
$1.32B
| $492K | 0.01% |
+39,767
| New | +$492K |
|
267
Intuitive Surgical
ISRG
$167B
| $488K | 0.01% |
+935
| New | +$488K |
|
268
Vera Therapeutics
VERA
$1.54B
| $488K | 0.01% |
11,531
-19,921
| -63% | -$842K |
|
269
Texas Instruments
TXN
$171B
| $469K | 0.01% |
2,500
+1,250
| +100% | +$234K |
|
270
ServiceNow
NOW
$190B
| $464K | 0.01% |
+438
| New | +$464K |
|
271
Dell
DELL
$84.4B
| $461K | 0.01% |
+4,000
| New | +$461K |
|
272
Denali Therapeutics
DNLI
$2.26B
| $429K | 0.01% |
21,039
-9,705
| -32% | -$198K |
|
273
Inovio Pharmaceuticals
INO
$148M
| $412K | 0.01% |
+225,000
| New | +$412K |
|
274
PagerDuty
PD
$1.54B
| $411K | 0.01% |
+22,500
| New | +$411K |
|
|
BOLD
275
Boundless Bio
BOLD
$25.7M
| $406K | 0.01% |
140,000
+86,832
| +163% | +$252K |
|